GlassScriptPhysician profile
Amit K Chakravarty
NPI 1154352326
$25,600.98
in general payments reported to CMS, 2019-2025
45 companies · $4,280 in 2025
The $4,280 reported for 2025 was more than what 87% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,564 · 2020: $2,359 · 2021: $2,987 · 2022: $6,344 · 2023: $4,017 · 2024: $4,050 · 2025: $4,280.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $240.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,106.43 |
| Education | $240.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,578.28 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $3,277.32 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Ethicon INC. | $2,421.23 | 2021-2023 | Monarch Platform |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,015.93 | 2019-2025 | Ofev, Jascayd, Stiolto Respimat |
| Grifols USA, LLC | $1,941.73 | 2019-2025 | Prolastin-C Liquid |
| Actelion Pharmaceuticals US, INC. | $1,180.86 | 2020-2025 | Uptravi, Opsumit, Opsynvi |
| Takeda Pharmaceuticals U.S.A., INC. | $1,167.08 | 2021-2025 | Glassia |
| Mallinckrodt Hospital Products INC. | $1,101.66 | 2020-2025 | Acthar |
| Philips North America LLC | $942.13 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Inogen, INC. | $933.39 | 2021-2025 | Inogen |
| Covidien LP | $756.52 | 2020 | |
| Genzyme Corporation | $627.31 | 2019-2025 | |
| United Therapeutics Corporation | $517.27 | 2019-2025 | Tyvaso, Tyvaso, Orenitram |
| Merck Sharp & Dohme LLC | $504.02 | 2021-2025 | Winrevair, Zerbaxa, Keytruda |
| Baxter Healthcare | $423.35 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $407.88 | 2021-2025 | Tezspire |
| Regeneron Healthcare Solutions, INC. | $344.41 | 2019-2025 | Dupixent |
| Ani Pharmaceuticals, INC. | $330.37 | 2022-2025 | Purified Cortrophin Gel |
| Insmed, INC. | $292.23 | 2019-2025 | Arikayce, Brinsupri |
| Mylan Specialty L.P. | $288.03 | 2020-2024 | Yupelri |
| Viatris Specialty LLC | $190.34 | 2025 | Yupelri |
| Pulmonx Corporation | $136.90 | 2022-2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Medical Device Business Services, INC. | $127.00 | 2022 | |
| Genentech USA, INC. | $104.52 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $103.26 | 2019-2025 | |
| Sunovion Pharmaceuticals INC. | $101.14 | 2019 | |
| Inspire Medical Systems, INC. | $98.33 | 2023-2024 | Inspire |
| Electromed, INC. | $97.93 | 2021-2023 | Smartvest |
| Advanced Respiratory, INC | $95.72 | 2021 | |
| Paratek Pharmaceuticals, INC. | $79.61 | 2024 | Nuzyra |
| Vifor Pharma, INC. | $77.82 | 2024-2025 | Zemaira |
| Johnson & Johnson Health Care Systems INC. | $60.00 | 2024-2025 | Opsumit, Uptravi |
| Circassia INC. | $36.02 | 2019-2020 | |
| Apria Healthcare LLC | $34.24 | 2021 | |
| Fisher & Paykel Healthcare INC | $29.10 | 2019-2021 | |
| Sanofi US Services INC. | $27.52 | 2024 | |
| Pfizer INC. | $24.58 | 2023 | |
| Mallinckrodt Enterprises LLC | $22.82 | 2019 | |
| Liquidia Technologies, INC. | $18.20 | 2025 | Yutrepia |
| Horizon Therapeutics Plc | $17.35 | 2020 | |
| Olympus America INC. | $16.18 | 2020 | |
| Verona Pharma, INC. | $14.88 | 2025 | Ohtuvayre |
| Sandoz INC. | $13.21 | 2024 | Treprostinil |
| Teva Pharmaceuticals USA, INC. | $12.08 | 2021 | |
| Gilead Sciences, INC. | $11.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Chakravarty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.